These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 21081951)

  • 1. Fundamental functionality: recent developments in understanding the structure-activity relationships of lantibiotic peptides.
    Ross AC; Vederas JC
    J Antibiot (Tokyo); 2011 Jan; 64(1):27-34. PubMed ID: 21081951
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The biology of lantibiotics from the lacticin 481 group is coming of age.
    Dufour A; Hindré T; Haras D; Le Pennec JP
    FEMS Microbiol Rev; 2007 Mar; 31(2):134-67. PubMed ID: 17096664
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lantibiotic engineering: molecular characterization and exploitation of lantibiotic-synthesizing enzymes for peptide engineering.
    Nagao J; Aso Y; Shioya K; Nakayama J; Sonomoto K
    J Mol Microbiol Biotechnol; 2007; 13(4):235-42. PubMed ID: 17827974
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structural characterization of lacticin 3147, a two-peptide lantibiotic with synergistic activity.
    Martin NI; Sprules T; Carpenter MR; Cotter PD; Hill C; Ross RP; Vederas JC
    Biochemistry; 2004 Mar; 43(11):3049-56. PubMed ID: 15023056
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sequential actions of the two component peptides of the lantibiotic lacticin 3147 explain its antimicrobial activity at nanomolar concentrations.
    Morgan SM; O'connor PM; Cotter PD; Ross RP; Hill C
    Antimicrob Agents Chemother; 2005 Jul; 49(7):2606-11. PubMed ID: 15980326
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A system for the random mutagenesis of the two-peptide lantibiotic lacticin 3147: analysis of mutants producing reduced antibacterial activities.
    Field D; Collins B; Cotter PD; Hill C; Ross RP
    J Mol Microbiol Biotechnol; 2007; 13(4):226-34. PubMed ID: 17827973
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Complete alanine scanning of the two-component lantibiotic lacticin 3147: generating a blueprint for rational drug design.
    Cotter PD; Deegan LH; Lawton EM; Draper LA; O'Connor PM; Hill C; Ross RP
    Mol Microbiol; 2006 Nov; 62(3):735-47. PubMed ID: 17076667
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Insights into the mode of action of the two-peptide lantibiotic haloduracin.
    Oman TJ; van der Donk WA
    ACS Chem Biol; 2009 Oct; 4(10):865-74. PubMed ID: 19678697
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ring A of nukacin ISK-1: a lipid II-binding motif for type-A(II) lantibiotic.
    Islam MR; Nishie M; Nagao J; Zendo T; Keller S; Nakayama J; Kohda D; Sahl HG; Sonomoto K
    J Am Chem Soc; 2012 Feb; 134(8):3687-90. PubMed ID: 22329487
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mapping and identification of the region and secondary structure required for the maturation of the nukacin ISK-1 prepeptide.
    Nagao J; Morinaga Y; Islam MR; Asaduzzaman SM; Aso Y; Nakayama J; Sonomoto K
    Peptides; 2009 Aug; 30(8):1412-20. PubMed ID: 19481127
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Solid supported chemical syntheses of both components of the lantibiotic lacticin 3147.
    Liu W; Chan AS; Liu H; Cochrane SA; Vederas JC
    J Am Chem Soc; 2011 Sep; 133(36):14216-9. PubMed ID: 21848315
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis of a Novel Lantibiotic Using Mutacin II Biosynthesis Apparatus.
    Biswas S
    Microbiol Spectr; 2023 Feb; 11(1):e0303022. PubMed ID: 36645288
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dissecting structural and functional diversity of the lantibiotic mersacidin.
    Appleyard AN; Choi S; Read DM; Lightfoot A; Boakes S; Hoffmann A; Chopra I; Bierbaum G; Rudd BA; Dawson MJ; Cortes J
    Chem Biol; 2009 May; 16(5):490-8. PubMed ID: 19477413
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structural and functional diversity of microcins, gene-encoded antibacterial peptides from enterobacteria.
    Duquesne S; Petit V; Peduzzi J; Rebuffat S
    J Mol Microbiol Biotechnol; 2007; 13(4):200-9. PubMed ID: 17827970
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structure revision of the lantibiotic 97518.
    Maffioli SI; Potenza D; Vasile F; De Matteo M; Sosio M; Marsiglia B; Rizzo V; Scolastico C; Donadio S
    J Nat Prod; 2009 Apr; 72(4):605-7. PubMed ID: 19301921
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New developments and applications of bacteriocins and peptides in foods.
    Mills S; Stanton C; Hill C; Ross RP
    Annu Rev Food Sci Technol; 2011; 2():299-329. PubMed ID: 22129385
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lactococcal membrane-permeabilizing antimicrobial peptides.
    Zendo T; Yoneyama F; Sonomoto K
    Appl Microbiol Biotechnol; 2010 Sep; 88(1):1-9. PubMed ID: 20645082
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Posttranslationally modified bacteriocins--the lantibiotics.
    Guder A; Wiedemann I; Sahl HG
    Biopolymers; 2000; 55(1):62-73. PubMed ID: 10931442
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of essential and variable residues of nukacin ISK-1 by NNK scanning.
    Islam MR; Shioya K; Nagao J; Nishie M; Jikuya H; Zendo T; Nakayama J; Sonomoto K
    Mol Microbiol; 2009 Jun; 72(6):1438-47. PubMed ID: 19432794
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of a novel two-peptide lantibiotic, haloduracin, produced by the alkaliphile Bacillus halodurans C-125.
    Lawton EM; Cotter PD; Hill C; Ross RP
    FEMS Microbiol Lett; 2007 Feb; 267(1):64-71. PubMed ID: 17233677
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.